Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease: Cochrane systematic review

Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease: Cochrane systematic review is a topic covered in the Cochrane Abstracts.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease: Cochrane systematic review ID - 433263 BT - Cochrane Abstracts UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433263/all/Recombinant_human_insulin_like_growth_factor_I__rhIGF_I__for_the_treatment_of_amyotrophic_lateral_sclerosis_motor_neuron_disease:_Cochrane_systematic_review DB - Evidence Central DP - Unbound Medicine ER -